Bee product could ease kidney disease inflammation

NCT ID NCT07597005

Recruiting now Disease control Sponsor: Universidade Federal Fluminense Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a natural substance called red propolis can lower inflammation and oxidative stress in people with chronic kidney disease (stages 3-5) who are not yet on dialysis. Researchers will measure changes in inflammatory markers like IL-6 and TNF-α. The goal is to see if propolis can help manage disease complications, not cure the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome impaired renal function disease Inflammation inflammatory disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE INFLAMMATION KIDNEY DISEASE OXIDATIVE STRESS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Denise Mafra
RECRUITING

Rio de Janeiro, Rio de Janeiro, 22260050, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.